ArticleJournal of evaluation in clinical practice2026
Medication Adherence in Relation to Beliefs About Medicines and Health-Related Quality of Life Among Community-Dwelling Patients: A Cross-Sectional Analysis.
Article in Journal of evaluation in clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPoor medication adherence is a widespread challenge among community-dwelling patients, and contributes to adverse health outcomes. This study aimed to describe self-reported medication adherence and identify associated factors, focusing on beliefs about medicines and health-related quality of life (HRQoL).
methodsThis cross-sectional study was conducted from February to August 2024, enrolling a convenience sample of 301 consecutively recruited community-dwelling patients with chronic diseases. Medication adherence was assessed using the 5-item Medication Adherence Report Scale (MARS-5), HRQoL with the EQ-5D-5L, and medication beliefs with the Beliefs about Medicines Questionnaire (BMQ). Group comparisons were performed using the Mann-Whitney or Kruskal-Wallis test. Multivariable linear regression identified predictors of adherence, and Spearman correlation assessed the relationships between MARS-5 scores and BMQ Concerns and Necessity subscales.
resultsMARS-5 scores ranged from 7 to 25 (mean 22.37 ± 4.02). Overall, 43.19% of participants showed high adherence (score = 25). Higher adherence was associated with younger age, higher education, lower age-adjusted Charlson Comorbidity Index, living with family, and hypertension (all p < 0.05). Non-adherence was significantly correlated with all EQ-5D-5L dimensions (all p < 0.001). In multivariable linear regression, higher education, living with family, and the absence of anxiety/depression problems were independent predictors of better adherence (p < 0.05). Furthermore, BMQ-necessity scores positively correlated with adherence, whereas BMQ-concern scores showed a negative correlation.
conclusionsTailored interventions addressing demographic and psychosocial factors may improve medication adherence in chronic disease management. Future studies should develop and evaluate strategies targeting these factors across diverse populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.